Vimarsana
Biggest News Aggregation in the World

Single Intravenous News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Single Intravenous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Single Intravenous Today - Breaking & Trending Today

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-inf - Vimarsana News

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-inf

Published: January 8, 2024

KELOWNA BC / ACCESSWIRE / January 8, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF), a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical ne...

Source: pharmiweb.com
Related Topics:
United StatesSouth AustraliaJim GilliganPeter MolloyAustralian Securities ExchangeAdministration In ConcertTryp Therapeutics IncUniversity Of MichiganHuman Research Ethics CommitteeUniversity Of FloridaTryp TherapeuticsDose Escalation StudySingle IntravenousHealthy Adult ParticipantsChief Scientific OfficerAbdominal Pain RelatedIrritable Bowel SyndromeMassachusetts General HospitalInstitutional Review BoardPilot StudyOral PsilocybinIrritable BowelPrivate Placement
TRYP THERAPEUTICS ANNOUNCES SIGNIFICANT MILESTONE IN ITS CLINICAL TRIAL PROGRAM FOR TRP-8803 (IV-INFUSED PSILOCIN) - Vimarsana News

TRYP THERAPEUTICS ANNOUNCES SIGNIFICANT MILESTONE IN ITS CLINICAL TRIAL PROGRAM FOR TRP-8803 (IV-INFUSED PSILOCIN)

Published: January 8, 2024

, 01/08/2024 / 07:01, EST/EDT - EQS Newswire - Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange, Nasdaq OTC)KELOWNA BC / ACCESSWIRE / January 8, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF), a...

Source: pharmiweb.com
Related Topics:
United StatesSouth AustraliaJim GilliganPeter MolloyAustralian Securities ExchangeAdministration In ConcertTryp Therapeutics IncUniversity Of MichiganTradegate ExchangeCanadian Stock ExchangeHuman Research Ethics CommitteeUniversity Of FloridaRegulated Unofficial MarketTryp TherapeuticsDose Escalation StudySingle IntravenousHealthy Adult ParticipantsChief Scientific OfficerAbdominal Pain RelatedIrritable Bowel SyndromeMassachusetts General HospitalInstitutional Review BoardPilot StudyOral PsilocybinIrritable Bowel